» Articles » PMID: 37092349

Potential Mechanism for Hyperhomocysteinemia in Greyhound Dogs

Overview
Date 2023 Apr 24
PMID 37092349
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Greyhounds have been reported to have hyperhomocysteinemia (HHC), but the underlying mechanisms and clinical implications are unclear.

Hypothesis: Our primary aim was to assess serum concentrations of homocysteine (HCy) and related analytes in Greyhounds and to identify a likely metabolic pathway for HHC. A secondary aim was to determine whether HHC is associated with evidence of oxidative stress.

Animals: Healthy pet Greyhounds (n = 31) and non-sighthound control dogs (n = 15).

Methods: Analysis of serum HCy, cobalamin, folate, and methionine, and plasma cysteine, glutathione, and total 8-isoprostane concentrations.

Results: Homocysteine concentrations were higher in Greyhounds (median, 25.0 μmol/L) compared to controls (13.9 μmol/L; P < .0001). Cobalamin concentrations were lower in Greyhounds (median, 416 ng/L) compared to controls (644 ng/L; P = .004) and were inversely correlated with HCy (r = -0.40, P = .004). Serum concentrations of folate, which is regenerated when HCy is converted to methionine, also were inversely correlated with HCy (r = -0.47, P = .002). Serum methionine concentrations were more than 4-fold lower in Greyhounds (median, 3.2 μmol/L) compared to controls (median, 15.0 μmol/L), but this difference was not significant (P = .3). Plasma cysteine, glutathione, and 8-isoprostane concentrations did not differ significantly between groups.

Conclusions And Clinical Importance: Our findings suggest a primary defect in conversion of HCy to methionine in Greyhounds, with related impaired folate generation. Ineffective cycling by methionine synthase could lead to secondary cobalamin depletion. Notably, low serum folate and cobalamin concentrations can be observed in Greyhounds without signs of intestinal disease.

Citing Articles

Safety and Digestibility of a Novel Ingredient, Brewed Lamb Protein, in Healthy Adult Dogs.

French S, Cochrane C, Faurot M, Audibert P, Belloso T, Badri D Animals (Basel). 2025; 15(3).

PMID: 39943197 PMC: 11816251. DOI: 10.3390/ani15030427.


The impact of homocysteine on patients with diabetic nephropathy: a mendelian randomization study.

Wang B, Li H, Wang N, Li Y, Song Z, Chen Y Acta Diabetol. 2024; 62(1):123-130.

PMID: 39105808 DOI: 10.1007/s00592-024-02343-9.


Potential mechanism for hyperhomocysteinemia in Greyhound dogs.

Johnson K, Tiedeman T, Peterson H, Steiner J, Trepanier L J Vet Intern Med. 2023; 37(3):960-967.

PMID: 37092349 PMC: 10229318. DOI: 10.1111/jvim.16700.

References
1.
Lutz S, Sewell A, Bigler B, Riond B, Reusch C, Kook P . Serum cobalamin, urine methylmalonic acid, and plasma total homocysteine concentrations in Border Collies and dogs of other breeds. Am J Vet Res. 2012; 73(8):1194-9. DOI: 10.2460/ajvr.73.8.1194. View

2.
Watkins D, Rosenblatt D . Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011; 157C(1):33-44. DOI: 10.1002/ajmg.c.30288. View

3.
Moyer K, Trepanier L . Erythrocyte glutathione and plasma cysteine concentrations in young versus old dogs. J Am Vet Med Assoc. 2009; 234(1):95-9. DOI: 10.2460/javma.234.1.95. View

4.
Lopes R, Grutzner N, Berghoff N, Lidbury J, Suchodolski J, Steiner J . Analytic validation of a gas chromatography-mass spectrometry method for quantification of six amino acids in canine serum samples. Am J Vet Res. 2015; 76(12):1014-21. DOI: 10.2460/ajvr.76.12.1014. View

5.
McLeish S, Burt K, Papasouliotis K . Analytical quality assessment and method comparison of immunoassays for the measurement of serum cobalamin and folate in dogs and cats. J Vet Diagn Invest. 2019; 31(2):164-174. PMC: 6838819. DOI: 10.1177/1040638718824073. View